Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids

Background: Selective progesterone receptor modulator ulipristal acetate (UPA) is a drug used in management of symptomatic myomas. It was observed that the response to UPA treatment in uterine myomas varied amongst patients. An attempt was thus made at establishing predictive factors conducive to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Szydłowska, Iwona, Marciniak, Aleksandra, Nawrocka-Rutkowska, Jolanta, Rył, Aleksandra, Starczewski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037608/
https://www.ncbi.nlm.nih.gov/pubmed/32012826
http://dx.doi.org/10.3390/ijerph17030798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037608/
https://www.ncbi.nlm.nih.gov/pubmed/32012826
http://dx.doi.org/10.3390/ijerph17030798

Ejemplares similares